{"id":27416,"date":"2025-04-11T04:07:43","date_gmt":"2025-04-11T04:07:43","guid":{"rendered":"https:\/\/theasiantelegraph.global\/?p=27416"},"modified":"2025-04-11T04:07:44","modified_gmt":"2025-04-11T04:07:44","slug":"effort-global-clinical-study-chart-new-course-for-malaria-control","status":"publish","type":"post","link":"https:\/\/theasiantelegraph.global\/?p=27416","title":{"rendered":"EFFORT Global Clinical Study Chart New Course for Malaria Control"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

Karachi ; The findings of a major international clinical trial EFFORT, recently presented at a conference hosted by Aga Khan University (AKU), offer new hope for the global fight against Plasmodium vivax malaria \u2013 the most prevalent strain in Pakistan accounting for over 80% of cases in the country. The results hold significant promise for transforming how the disease is treated and, ultimately, eliminated.<\/p>\n\n\n\n

Plasmodium vivax poses a particular challenge to malaria control because it can lie dormant in the liver and cause relapses weeks or months after the initial infection. In Pakistan, one of the greatest hurdles to malaria control is ensuring that patients complete their full course of treatment \u2014 making effective and simpler treatment options urgently needed.<\/p>\n\n\n\n

The five-year trial compared three treatment approaches: the current global standard of low-dose primaquine (taken over 14 days), a shorter, high-dose primaquine regimen (7 days), and a single-dose of tafenoquine. Conducted in Karachi and Thatta \u2014 two malaria hotspots in Sindh \u2014 the trial\u2019s findings were clear: the latter two treatments significantly reduced the rate of malaria recurrence, with tafenoquine showing particularly strong potential for malaria control in Pakistan.<\/p>\n\n\n\n

\u201cMalaria is more than just a disease \u2014 it\u2019s an economic, political, and social challenge,\u201d said Prof Kamala Thriemer, a global malaria expert from the Menzies School of Health Research and chief investigator for the EFFORT trial. \u201cWhat made this trial unique was our commitment to testing treatment options as close to real-world conditions as possible. We focused on unsupervised regimens and tracked patients over time, including treating recurrences.\u201d<\/p>\n\n\n\n

The event included a panel discussion featuring representatives from the federal government, the provincial governments of Sindh and Baluchistan, AKU, and international experts. Together, they explored how to translate these findings into concrete policy changes and implementation strategies \u2014 from domestic drug manufacturing to funding, training, and public outreach.<\/p>\n\n\n\n

Prof Dr M. Asim Beg from AKU highlighted the human impact behind the data. \u201cWe are proud to serve communities like Thatta \u2014 some of the most impoverished, but also the most resilient, in the country. Achieving elimination will take collective willpower and a unified approach at every level.\u201d<\/p>\n\n\n\n

The EFFORT trial was conducted by a consortium of partners including the Menzies School of Health Research, MORU Tropical Health Network, Maastricht University, The University of Melbourne and AKU. The trial was funded by the Bill & Melinda Gates Foundation, and Australia\u2019s National Health and Medical Research Council (NHMRC). Its findings are expected to influence global treatment recommendations by supporting the rollout of more effective radical cures.<\/p>\n","protected":false},"excerpt":{"rendered":"

Karachi ; The findings of a major international clinical trial EFFORT, recently presented at a conference hosted by Aga Khan University (AKU), offer new hope for the global fight against… <\/p>\n","protected":false},"author":8,"featured_media":27417,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[1475,2093],"class_list":["post-27416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-aga-khan-universitys-malaria-elimination-consortium-aku-mec","tag-aku-health-services"],"_links":{"self":[{"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/posts\/27416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27416"}],"version-history":[{"count":1,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/posts\/27416\/revisions"}],"predecessor-version":[{"id":27418,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/posts\/27416\/revisions\/27418"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=\/wp\/v2\/media\/27417"}],"wp:attachment":[{"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theasiantelegraph.global\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}